A Phase 1 trial that is testing Modex's vaccine against the Epstein-Barr virus, a strong risk factor for MS, has dosed its ...

The researchers found that a biomarker in the blood called neurofilament light chain (NfL) increased after menopause. This ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...

When he was 25, he learned that he had multiple sclerosis. He coped with the disease throughout a long career at several ...

Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...